Organogenesis Holdings Inc - Class A

Research Organogenesis Holdings Inc - Class A (ORGO) on Bullrun: market cap USD 311.39M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerORGO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 311.39M
• Financial periodFY2025
• RevenueUSD 564.17M
• Revenue growth17.0%
• Net incomeUSD 37.00M
• Free cash flow-USD 24.46M

Valuation Snapshot

latest market cap is USD 311.39M.

About Organogenesis Holdings Inc - Class A

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds;

Frequently asked questions

What is Organogenesis Holdings Inc - Class A's market cap?

Organogenesis Holdings Inc - Class A's market capitalization is USD 311.39M.

What does Organogenesis Holdings Inc - Class A do?

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.